Maryla Krajewska

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

Toshiyuki Miyashita, Stanisław Krajewski, Maryla Krajewska et al. · PubMed · 1994 · 2.2K citations

Life Sciences, Cell Biology, Oncology +13

Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.

Stanisław Krajewski, Maryla Krajewska, Ahmed Shabaik et al. · PubMed · 1994 · 664 citations

Medicine, Molecular Medicine, Immunopathology +9

Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia

Stanisław Krajewski, Maryla Krajewska, Lisa Ellerby et al. · Proceedings of the National Academy of Sciences · 1999 · 543 citations

Life Sciences, Neurobiology, Neuroscience +17

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

Judith Hugh, John Hanson, Maggie C.U. Cheang et al. · Journal of Clinical Oncology · 2009 · 535 citations · Full text

Medicine, Oncology, Pharmacology +16

Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma

Randy D. Gascoyne, Sheryle A. Adomat, Stanisław Krajewski et al. · Blood · 1997 · 499 citations · Full text

Medicine, Oncology, Pathology +13